Strobeck Matthew

Average Profitability
6.55%
Insider Buys Quantity
22
Insider Buys Sum
$25.94M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Strobeck Matthew

According to the SEC Form 4 filings, Strobeck Matthew, being in a position of

  1. director at Accelerate Diagnostics, Inc.,
    оver the last 12 months, has bought 100000 shares for $150,000, and sold 0 shares,
    over all time since 2014-08-04, has bought 426470 shares for $5.41M, and sold 0 shares.

The largest purchase of all time was on 2015-12-15 and amounted to 176470 shares of Accelerate Diagnostics, Inc. for $3M.

Biography of Strobeck Matthew

No biography is available at this moment.

2024-11-05PurchaseBiodesix, Inc.
BDSX
director
40,000
0.0278%
$1.40$55,916-3.43%
2024-01-23PurchaseAccelerate Diagnostics, Inc.
AXDX
director
100,000
0.7643%
$1.50$150,000-4.55%
2022-11-21PurchaseBiodesix, Inc.
BDSX
director
2.34M
3.5863%
$1.15$2.69M+22.69%
2022-11-21PurchaseBiodesix, Inc.
BDSX
director
4.69M
7.1727%
$1.15$5.39M+22.69%
2022-04-07PurchaseBiodesix, Inc.
BDSX
1.68M
4.2712%
$1.79$3M-3.91%
2021-12-30PurchaseBiodesix, Inc.
BDSX
director
295,600
1.0655%
$4.35$1.29M-60.43%
2020-10-30PurchaseBiodesix, Inc.
BDSX
director
166,666
4.9886%
$18.00$3M+19.87%
2020-09-03PurchaseQuidelOrtho Corporation
QDEL
director
400
0.0009%
$155.63$62,254-4.68%
2020-09-02PurchaseQuidelOrtho Corporation
QDEL
director
7,300
0.0172%
$166.65$1.22M-9.74%
2020-03-18PurchaseAccelerate Diagnostics, Inc.
AXDX
director
10,000
0.0183%
$7.11$71,100+41.58%
2017-01-09PurchaseAccelerate Diagnostics, Inc.
AXDX
director
16,000
0.0288%
$19.00$304,000+20.27%
2016-02-09PurchaseAccelerate Diagnostics, Inc.
AXDX
director
40,000
0.0794%
$11.52$460,800+79.17%
2015-12-15PurchaseAccelerate Diagnostics, Inc.
AXDX
director
176,470
0.3064%
$17.00$3M-13.43%
2015-03-19PurchaseAccelerate Diagnostics, Inc.
AXDX
director
4,000
0.009%
$22.04$88,160-12.12%
2014-08-22PurchaseYield10 Bioscience, Inc.
YTEN
director
5.85M
8.0567%
$0.50$2.92M-1.54%
2014-08-05PurchaseAccelerate Diagnostics, Inc.
AXDX
director
40,000
0.094%
$16.70$668,000+37.01%
2014-08-04PurchaseAccelerate Diagnostics, Inc.
AXDX
director
40,000
0.0923%
$16.70$668,000+34.17%
2013-11-29PurchaseYield10 Bioscience, Inc.
YTEN
director
80,000
0.2191%
$1.06$84,592-13.39%
2013-11-27PurchaseYield10 Bioscience, Inc.
YTEN
director
20,000
0.054%
$0.79$15,834+15.29%
2012-11-30PurchaseYield10 Bioscience, Inc.
YTEN
director
155,000
0.4406%
$1.10$170,785+34.51%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.